SCHEMBL17628378

SCHEMBL17628378

O=C(O)NC1CCCN(c2nc(Cl)nc3cccnc23)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.44
OPRK1 P41145 2/20 0.41
OPRM1 P35372 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
CNR1 P21554 1/20 0.41
PDE10A Q9Y233 1/20 0.40
CNR2 P34972 3/20 0.39
ACKR3 P25106 1/20 0.38
PIK3R1 P27986 1/20 0.38
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
BTK Q06187 3/20 0.38
LCK P06239 1/20 0.38
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17627958 0.94 OPRK1 (0.44) OPRK1OPRM1OGFRL1MEN1KMT2A
SCHEMBL17628070 0.91 CNR2 (0.47) PRKDCOPRK1OPRM1OGFRL1MEN1
SCHEMBL17628072 0.91 CNR2 (0.47) PRKDCOPRK1OPRM1OGFRL1MEN1
SCHEMBL17628004 0.84 CNR2 (0.53) OPRK1OPRM1OGFRL1CNR2ACKR3
SCHEMBL17628001 0.84 CNR2 (0.53) OPRK1OPRM1OGFRL1CNR2ACKR3
SCHEMBL17627938 0.79 HRH4 (0.43) PDE10APIK3CAMTOR
SCHEMBL17627939 0.79 HRH4 (0.43) PDE10APIK3CAMTOR
SCHEMBL26911669 0.78 OPRM1 (0.49) PRKDCOPRK1OPRM1OGFRL1PDE10A
SCHEMBL17667296 0.77 PRKDC (0.40) PRKDCKMT2APDE10ACNR2PIK3CA
SCHEMBL17667297 0.77 PRKDC (0.40) PRKDCKMT2APDE10ACNR2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORPORATION (KR) 2017-06-01 US disclosed
EP-3006439-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR Yuhan Corporation (KR) 2016-04-13 EP disclosed
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORP (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 PRKDC 4342/4885OPRK1 977/4885OPRM1 769/4885
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 PRKDC 4342/4885OPRK1 977/4885OPRM1 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.